No abstract

No abstract

Multiple sclerosis (MS) is a neurodegenerative disorder characterized by periodic neuronal demyelination, which leads to a range of symptoms and eventually to disability. The goal of this research was to use UPLC-Orbitrap/MS to identify validated biomarkers and explore the metabolic mechanisms of MS in mice. Thirty-two C57BL/6 male mice were randomized into two groups that were fed either normal food or 0.2% CPZ for 11 weeks. The mouse demyelination model was assessed by LFB and the expression of MBP by immunofluorescence and immunohistochemistry. The metabolites of the corpus callosum were quantified using UPLC-Orbitrap/MS. The mouse pole climbing experiment was used to assess coordination ability. Multivariate statistical analysis was adopted for screening differential metabolites, and the ingenuity pathway analysis (IPA) was used to reveal the metabolite interaction network. We successfully established the demyelination model. The CPZ group slowly lost weight and showed an increased pole climbing time during feeding compared to the CON group. A total of 81 metabolites ( VIP > 1 and P < 0.05 ) were determined to be enriched in 24 metabolic pathways; 41 metabolites were markedly increased, while 40 metabolites were markedly decreased in the CPZ group. The IPA results revealed that these 81 biomarker metabolites were associated with neuregulin signaling, PI3K-AKT signaling, mTOR signaling, and ERK/MAPK signaling. KEGG pathway analysis showed that two significantly different metabolic pathways were enriched, namely, the glycerophospholipid and sphingolipid metabolic pathways, comprising a total of nine biomarkers. Receiver operating characteristic analysis showed that the metabolites (e.g., PE (16 : 0/22 : 6(4Z, 7Z, 10Z, 13Z, 16Z, 19Z)), PC (18 : 0/22 : 4(7Z, 10Z, 13Z, 16Z)), cytidine 5 ′ -diphosphocholine, PS (18 : 0/22 : 6(4Z, 7Z, 10Z, 13Z, 16Z, 19Z)), glycerol 3-phosphate, SM (d18 : 0/16 : 1(9Z)), Cer (d18:1/18 : 0), galabiosylceramide (d18:1/18 : 0), and GlcCer (d18:1/18 : 0)) have good discrimination ability for the CPZ group. In conclusion, the differential metabolites have great potential to serve as biomarkers of demyelinating diseases. In addition, we identified metabolic pathways associated with CPZ-induced demyelination pathogenesis, which provided a new perspective for understanding the relationship between metabolites and CNS demyelination pathogenesis.

No abstract

No abstract

Multiple sclerosis (MS) is an incurable and progressive neurodegenerative disease that affects more than 2.5 million people worldwide and brings tremendous economic pressures to society. However, the pathophysiology of MS is still not fully elucidated, and there is no effective treatment. Demyelination is thought to be the primary pathophysiological alteration in MS, and our previous study found abnormal lipid metabolism in the demyelinated corpus callosum. Growing evidence indicates that central nervous system (CNS) demyelinating diseases never result from one independent factor, and the simultaneous participation of abnormal lipid metabolism, oxidative stress, and neuroinflammation could potentiate each other in the pathogenesis of MS. Therefore, a single omics analysis cannot provide a full description of any neurodegenerative disease. It has been demonstrated that oxidative stress and neuroinflammation are two reciprocal causative reasons for the progression of MS disease. However, the potential crosstalk between oxidative stress and neuroinflammation remains elusive so far. With an integrated analysis of targeted lipidomics and transcriptomics, our research presents the potential interaction between abnormalities of lipid metabolism, mitochondrial dysfunction, oxidative stress, and neuroinflammation in CNS demyelinating diseases. The findings of this paper may be used to identify possible targets for the therapy of CNS demyelinating diseases.

Silica aerogel (SiO 2 aerogel) was prepared by solgel method from tetraethyl orthosilicate hydrolyzation and has been characterized by scanning electron microscopy and N 2 adsorption for its surface structure, surface area, and poresize distribution. Constant current charge-discharge technique, cyclic voltammetry, and electrochemical impedance spectrum were employed for its specific capacitance and equivalent series resistance. The results showed that the maximum specific capacitance of SiO 2 aerogel electrode in 1 M Et 4 NBF 4 /PC electrolyte was 62.5 F g −1 . In addition, the SiO 2 aerogel capacitor exhibits excellent long-term stability with no significant degradation after 500 charging and discharging cycles. Therefore, the application of high surface area SiO 2 aerogel as electrodes in supercapacitor devices is promising.

C/C-SiC-(ZrxHf1−x)C composites were prepared by the reactive melt infiltration method. The microstructure of the porous C/C skeleton and the C/C-SiC-(ZrxHf1−x)C composites, as well as the structural evolution and ablation behavior of the C/C-SiC-(ZrxHf1−x)C composites, were systematically investigated. The results show that the C/C-SiC-(ZrxHf1−x)C composites were mainly composed of carbon fiber, carbon matrix, SiC ceramic, (ZrxHf1−x)C and (ZrxHf1−x)Si2 solid solutions. The refinement of the pore structure is beneficial to promote the formation of (ZrxHf1−x)C ceramic. The C/C-SiC-(ZrxHf1−x)C composites exhibited outstanding ablation resistance under an air–plasma environment at around 2000 °C. After ablation for 60 s, CMC-1 appeared to possess the minimum mass and linear ablation rates of only 2.696 mg/s and −0.814 µm/s, respectively, which are lower than those of CMC-2 and CMC-3. During the ablation process, a Bi-liquid phase and a liquid–solid two-phase structure were formed on the ablation surface which could act as an oxygen diffusion barrier to retard further ablation, which is responsible for the excellent ablation resistance of the C/C-SiC-(ZrxHf1−x)C composites.